OOIR: Observatory of International Research

Papers

(The median citation count of Cancer Journal is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Toxicities From Antibody-Drug Conjugates	138
Social Drivers of Cancer Risk and Outcomes Among African American Men	28
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	28
Oncology Physician Workforce Diversity	26
PET Imaging of Metabolism, Perfusion, and Hypoxia	24
Building a Bridge to Equity in Health and Health Care in Cancer Care	24
Health Care Policy and Disparities in Health	23
c-Met Signaling as a Therapeutic Target in Head and Neck Cancer	21
Stereotactic Body Radiation Therapy	21
Melanoma—Modern Treatment for Metastatic Melanoma	20
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer	19
Nonoperative Management for Rectal Cancer	18
Evaluation of the Prognostic Role of Liver Metastases on Patient Outcomes	18
Tumor-Infiltrating Lymphocyte and Other Cell Therapies for Metastatic Melanoma	17
Germline Predisposition to Myelodysplastic Syndromes	15
Metastatic Melanoma Treatment in Special Populations	14
Aurora Kinases as Therapeutic Targets in Head and Neck Cancer	14
Prostate Cancer, Race, and Health Disparity	13
Rectal Cancer—The Only Constant Is Change	13
Antibody Drug Conjugates in Multiple Myeloma	13
Diversity in Cancer Care	13
Primary Prevention of Cancer	13
Current State of Neoadjuvant Therapy for Locally Advanced Rectal Cancer	12
Overlooked and Damaging Impact of Structural Racism and Implicit Bias on US Health Care	12
Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndromes	12

Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	11
Updates in the Management of Uveal Melanoma	11
Advances in Stereotactic Body Radiation Therapy for Lung Cancer	11
Overview of the Management of Higher-Risk Myelodysplastic Syndromes	11
New Metabolomic Insights Into Cancer	10
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	10
Supportive Care for Patients With Myelodysplastic Syndromes	10
Introduction	10
Menopausal Hormone Therapy and Breast Cancer	10
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	10
Impact of Precision Medicine in Oncology	9
How Far We’ve Come	9
PI3K Inhibition for Squamous Cell Head and Neck Carcinoma	9
Hormone Replacement Therapy After Breast Cancer	8
Telemedicine and cancer care: Barriers and strategies to optimize delivery: Erratum	8
Role of the Microbiome in Immunotherapy of Melanoma	8
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	7
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	7
Estrogen for the Treatment and Prevention of Breast Cancer	7
Discovery of Natural Products for Cancer Prevention	7
Survival of the Fittest	7
What Role Does Radiotherapy Play in the Molecular Era for Intrahepatic Cholangiocarcinoma?	7
Telehealth and Technology	7
Spectrum From Clonal Hematopoiesis to Myelodysplastic Neoplasm/Syndromes and Other Myeloid Neoplasms	7
Current State of Cell Therapies for Genitourinary Malignancies	7
The Lung Microbiome in Carcinogenesis and Immunotherapy Treatment	6
Telemedicine and Cancer Care	6
STING Agonists in Head and Neck Squamous Cell Carcinoma	6
Gene Expression Profiles in Cancers and Their Therapeutic Implications	6
Individual Benefits and Risks of Intravaginal Estrogen and Systemic Testosterone in the Management of Women in the Menopause, With a Discussion of Any Associated Risks for Cancer Development	6
Repurposing Drugs for Cancer Prevention	6
What to Eat for Cancer Prevention	6
Molecular Imaging of Steroid Receptors in Breast Cancer	6
The Microbiome and Its Impact on Allogeneic Hematopoietic Cell Transplantation	5
Severe Lymphopenia Predicts Poorer Survival in Patients With Rectal Cancer Undergoing Neoadjuvant Chemoradiation	5
Updates in Classification of Myelodysplastic Syndrome	5
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	5
Diagnostic and Therapeutic Application of Fibroblast Activation Protein Inhibitors in Oncologic and Nononcologic Diseases	5
Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer	5
Local Excision for Early-Stage Rectal Adenocarcinomas	5
Radiopharmaceuticals for Cancer Diagnosis and Therapy	5
Antibody-Drug Conjugates in Myeloid Leukemias	5
The Gut Microbiome and Pancreatic Cancer Development and Treatment	5
Impact of Precision Medicine in Oncology	5
Chimeric Antigen Receptor T-Cell Therapy	5
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	5
Adoptive Cell Therapy for Advanced Solid Tumors	4
Digital Health for Oncological Care	4
Management of Low-Grade Gliomas	4
Telemedicine and Burnout—How Enhancing Operational Support Can Improve Digital Health Tools	4

Effective Image Communication of Hormone Replacement Therapy Risks and Benefits	4
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	4
Introduction	4
The Management of Low-Risk Myelodysplastic Syndromes—Current Standards and Recent Advances	4
Antibody-Drug Conjugates and Tissue-Agnostic Drug Development	4
Advancements in Understanding and Preventing Obesity-Related Colon Cancer	4
The Utility of Interim Positron Emission Tomography Imaging to Inform Adaptive Radiotherapy for Head and Neck Squamous Cell Carcinoma	4
Nuclear Medicine Cancer Care—Current Status and Future Directions for Radiopharmaceutical Diagnostics and Theranostics for Cancer	4
Treatment of Stage III Resectable Melanoma—Adjuvant and Neoadjuvant Approaches	4
A Review of Stereotactic Body Radiotherapy in the Management of Gastrointestinal Malignancies	3
Preclinical In Vitro and In Vivo Models for Adoptive Cell Therapy of Cancer	3
Neoantigen-Specific T Cells in Adoptive Cell Therapy	3
T3N0 Rectal Cancer	3
Targets for Cancer Prevention: Evolving Methodologies in Basic and Epidemiological Sciences Identify Interrelated Pathways and the Need for Holistic Approaches	3
Fecal Microbiota Transplantation as a Cancer Therapeutic	3
Diversity and Disparities in Lung Cancer Outcomes Among Minorities	3
The Menopause Management Vacuum	3
The Role of Circulating Tumor DNA for Management of Patients With Rectal Cancer	3
Shifting the Landscape of Spine and Non-Spine Bone Metastases	3
The Promise of Cancer Health Justice	3